← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2001Last known activity
Jun 13, 2022
Timeline
1980s
- Jan 1, 1989
Stanley Medical Research Institute— Founded
Drugs by trial phase (109 distinct, 129 trials)
Phase 4 (28 own, 0 via acquisition)
Phase 3 (31 own, 0 via acquisition)
Phase 2 (31 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (17 own, 0 via acquisition)
Indications
Studied for
- Alcohol Drinking
- Alcoholism
- Autism Spectrum Disorder
- Bipolar Disorder
- Cognitive Dysfunction
- Depression
- Depressive Disorder
- Disease
- Dyskinesias
- Herpes Simplex
- Inflammation
- Insulin Resistance
- Major Depressive Disorder
- Mental Disorders
- Mood Disorders
- Neurobehavioral Manifestations
- Prodromal Symptoms
- Psychotic Disorders
- Recurrence
- Schizophrenia
- Substance-Related Disorders
- Tardive Dyskinesia
- Toxoplasmosis
- Weight Gain
Recent trials (50)
- NCT05204407CollaboratorN/AJun 13, 2022
- NCT04887792CollaboratorPhase 1/Phase 2Dec 1, 2021
- NCT04211961CollaboratorPhase 2Feb 29, 2020
- NCT04093518CollaboratorPhase 2/Phase 3Oct 15, 2019
- NCT03794076CollaboratorPhase 1/Phase 2Apr 1, 2019
- NCT03437668CollaboratorPhase 2/Phase 3Apr 1, 2018
- NCT03013400CollaboratorPhase 2Jun 30, 2017
- NCT03010865CollaboratorPhase 2/Phase 3Jun 1, 2017
- NCT02703363CollaboratorPhase 3Aug 1, 2016
- NCT02800161CollaboratorPhase 3Jun 1, 2016
- NCT02796859CollaboratorPhase 1/Phase 2May 1, 2016
- NCT02654405CollaboratorPhase 2/Phase 3Apr 1, 2016
- NCT02685748CollaboratorPhase 2/Phase 3Mar 1, 2016
- NCT03848234CollaboratorPhase 3Dec 4, 2015
- NCT02686697CollaboratorPhase 2/Phase 3Dec 1, 2015
Details
- Founded
- Chevy Chase, MD, US Jan 1, 1989
- Last known activity
- Jun 13, 2022